Abstract

Introduction: Vascular access thrombosis increases the risk of mortality and morbidity in end-stage renal disease (ESRD) patients on hemodialysis (HD). This study aimed to evaluate hereditary thrombophilia factors in HD patients and its association with tunneled cuffed catheters’ thrombosis. Methods: In this cross-sectional study, 60 consecutive patients with ESRD on HD with tunneled cuffed catheters were selected. Inherited thrombophilia factors (Anti-thrombin III, Protein C, Protein S, and Factor V Leiden) were measured and the patients were followed for 3 months to evaluate the incidence of catheter-related thrombosis. The association between these factors and catheter thrombosis was assessed. Results: The mean age of patients was 60.30 ± 8.69 years. Forty-seven patients (78.30%) were female and thirteen patients (21.70%) were male. The most common cause of ESRD was diabetes mellitus (41.67%). The most catheter site was the right internal jugular vein (55%). There were 22 (36.67%) and 8 (13.33%) cases of thrombosis and mortality, respectively. The association between hereditary thrombophilia factors and catheter thrombosis was not statistically significant (P > 0.05). Conclusion: In this small group of our patients, the frequency of hereditary thrombophilia was not significantly different between those with and without thrombosis of tunneled HD catheter.

Highlights

  • Vascular access thrombosis increases the risk of mortality and morbidity in endstage renal disease (ESRD) patients on hemodialysis (HD)

  • The best option for hemodialysis is creation of a native arteriovenous fistula (AVF), tunneled cuffed HD catheters are still used in a considerable number of patients.[3,4,5]

  • There is a paucity of data on the role of hereditary thrombophilia for thrombosis of a tunneled HD catheter in ESRD patients

Read more

Summary

Introduction

Vascular access thrombosis increases the risk of mortality and morbidity in endstage renal disease (ESRD) patients on hemodialysis (HD). This study aimed to evaluate hereditary thrombophilia factors in HD patients and its association with tunneled cuffed catheters’ thrombosis. Inherited thrombophilia factors (Anti-thrombin III, Protein C, Protein S, and Factor V Leiden) were measured and the patients were followed for 3 months to evaluate the incidence of catheter-related thrombosis. Deficiency of anticoagulation proteins, including anti-thrombin III, protein C and S and factor V Leiden is associated with inherited thrombophilia which enhances the hypercoagulability state in patients on HD.[9,10,11] Investigating the role of inherited thrombophilia factors may help decrease the risk of catheter failure due to thrombosis in such patients.

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call